TCES2016 Session 3: Clinical and Commercial Translation

Session 3: Clinical and Commercial Translation

Sponsor: The Cell and Gene Therapy Catapult 

Chairs: James Phillips and Melanie Georgiou

Introductions by Dr Hadi Mirmalek-Sani, Cell and Gene Therapy Catapult

Keynote: Dr John Sinden, ReNeuron plc.

The CTX neural stem cell line, moving forward in multiple therapy indications

<separate post>

Eloy Erro, University College London

UCL-BAL: Development of three-dimensional mammalian cell culture at clinical scale

Laura Sidney, University of Nottingham

Investigation into the importance of maintaining CD34 expression in the
therapeutic potential of corneal stroma-derived stem cells

Clare Selden, University College London

A BioArtificial Liver machine to treat patients with acute liver failure:
pivotal results in a pre- clinical trial

Vanessa Hearnden (Sabiniano Roman), University of Sheffield

Angiogenic potential of adipose derived stem cells compared to the
stromal vascular fraction